Dr. Tulin Budak-Alpdogan
Claim this profileCooper Hospital University Medical Center
Studies Lymphoma
Studies Plasma Cell Neoplasms
5 reported clinical trials
16 drugs studied
Area of expertise
1Lymphoma
Stage IV
Stage III
13q positive
2Plasma Cell Neoplasms
Affiliated Hospitals
Clinical Trials Tulin Budak-Alpdogan is currently running
SPd vs EloPd Chemotherapy
for Multiple Myeloma
This phase 3 randomized, open-label multicenter trial will compare the efficacy, safety and the impact on health-related quality of life (HR-QoL) of SPd versus EloPd in pomalidomide-naïve patients with MM who have received 1 to 4 prior anti-MM regimens and been treated with an immunomodulatory imide drug (IMiD), proteasome inhibitor (PI) and an anti-CD38 monoclonal antibody (mAb).
Recruiting2 awards Phase 318 criteria
Lenalidomide +/- Daratumumab
for Multiple Myeloma
Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2. Patients are followed until they will begin Maintenance and then registered to Reg Step 2 (first randomization). Patients are randomized between Lenalidomide for 2 years and Lenalidomide + Daratumumab/rHuPH20. After 2 years of Maintenance, MRD is assessed to guide further therapy. MRD-positive patients will continue with the assigned treatment. MRD-negative patients will be further randomized (Reg Step 3) to either continue or discontinue the assigned treatment. Patients are treated for up to 7 years from Step 2 reg and followed for up to 15 years.
Recruiting2 awards Phase 317 criteria
More about Tulin Budak-Alpdogan
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Tulin Budak-Alpdogan has experience with
- Brentuximab Vedotin
- Lenalidomide
- Selinexor
- Elotuzumab
- Dexamethasone Oral
- Pomalidomide
Breakdown of trials Tulin Budak-Alpdogan has run
Lymphoma
Plasma Cell Neoplasms
Multiple Myeloma
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Tulin Budak-Alpdogan specialize in?
Tulin Budak-Alpdogan focuses on Lymphoma and Plasma Cell Neoplasms. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are Stage III.
Is Tulin Budak-Alpdogan currently recruiting for clinical trials?
Yes, Tulin Budak-Alpdogan is currently recruiting for 3 clinical trials in Camden New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Tulin Budak-Alpdogan has studied deeply?
Yes, Tulin Budak-Alpdogan has studied treatments such as Brentuximab Vedotin, Lenalidomide, Selinexor.
What is the best way to schedule an appointment with Tulin Budak-Alpdogan?
Apply for one of the trials that Tulin Budak-Alpdogan is conducting.
What is the office address of Tulin Budak-Alpdogan?
The office of Tulin Budak-Alpdogan is located at: Cooper Hospital University Medical Center, Camden, New Jersey 08103 United States. This is the address for their practice at the Cooper Hospital University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.